Related Experiment Video
Updated: Feb 15, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
Shengzhe Zhang1,2, Meiying Zhang3, Ying Jing1
1State Key Laboratory of Oncogenes and Related Genes, Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Abstract:
MCL1 is a pivot member of the anti-apoptotic BCL-2 family proteins. While a distinctive feature of MCL1 resides in its efficient ubiquitination and destruction, the deubiquitinase USP9X has been implicated in the preservation of MCL1 expression by removing the polyubiquitin chains. Here we perform an unbiased siRNA screen and identify that the second deubiquitinase, USP13, regulates MCL1 stability in lung and ovarian cancer cells. Mechanistically, USP13 interacts with and stabilizes MCL1 via deubiquitination. As a result, USP13 depletion using CRISPR/Cas9 nuclease system inhibits tumor growth in xenografted nude mice. We further report that genetic or pharmacological inhibition of USP13 considerably reduces MCL1 protein abundance and significantly increases tumor cell sensitivity to BH3 mimetic inhibitors targeting BCL-2 and BCL-XL. Collectively, we nominate USP13 as a novel deubiquitinase which regulates MCL1 turnover in diverse solid tumors and propose that USP13 may be a potential therapeutic target for the treatment of various malignancies.
Insights
The deubiquitinase USP13 stabilizes MCL1, a protein promoting cancer cell survival. Inhibiting USP13 reduces MCL1, hindering tumor growth and increasing sensitivity to cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- MCL1 is a key anti-apoptotic protein in the BCL-2 family.
- MCL1 expression is regulated by ubiquitination and deubiquitination.
- USP9X is known to stabilize MCL1 by removing polyubiquitin chains.
Purpose of the Study:
- To identify novel deubiquitinases regulating MCL1 stability.
- To investigate the role of USP13 in cancer cell survival and tumor growth.
- To evaluate USP13 as a potential therapeutic target.
Main Methods:
- Unbiased siRNA screening to identify regulators of MCL1.
- CRISPR/Cas9 gene editing for USP13 depletion.
- Xenograft mouse models to assess tumor growth inhibition.
- Western blotting to analyze protein levels and ubiquitination status.
Main Results:
- USP13 was identified as a novel deubiquitinase that stabilizes MCL1.
- USP13 interacts with and deubiquitinates MCL1, preserving its expression.
- USP13 depletion inhibited tumor growth in vivo.
- Inhibition of USP13 reduced MCL1 protein levels and sensitized cancer cells to BH3 mimetics.
Conclusions:
- USP13 is a novel regulator of MCL1 turnover in solid tumors.
- USP13 inhibition represents a potential therapeutic strategy for various malignancies.
- Targeting USP13 may enhance the efficacy of existing cancer treatments.
More Related Videos
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Nuclear Stability
To hold positively charged protons together...
RNA Stability
Stability
The stability of an LTI system is determined by the roots of its characteristic equation, known as poles. A system is stable if it produces a bounded...
Stability of structures
Pole and System Stability
Simple poles are unique roots of the denominator polynomial. Each simple pole corresponds to a distinct solution to the system's characteristic equation, typically resulting in exponential decay terms in the system's...

